How organ-on-a-chip models can help drug development
This month’s Going on Trial newsletter explores how organ-on-a-chip models could smooth the transition from preclinical to clinical trials, among other drug development news.
This month’s Going on Trial newsletter explores how organ-on-a-chip models could smooth the transition from preclinical to clinical trials, among other drug development news.
This week on social media, researchers discussed research on sensory issues in fragile X mice, and they considered yet another study of epidurals and autism. That and more in this week’s Community Newsletter.
Knocking down the gene that codes for the proteins normalizes the vocalizations.
A total of 17 studies have already been retracted or are slated for retraction over issues with participant consent.
The mutation increases the activity of an autism-linked protein and leads to social difficulties and other behavioral differences in mice.
Researchers discussed a study of the integrated stress response in fragile X syndrome and a new how-to guide for quantitative bioimaging — plus more in this week’s Community Newsletter.
Children with congenital heart disease have an increased likelihood of autism. Why?
A new technique used to create see-through rodents can help scientists analyze how the nervous system interacts with other body systems.
The inhibitory cells misfire and contribute to social difficulties in mice that model the syndrome.
The request is energizing scientists investigating autistic people who largely don’t communicate with spoken words.